scholarly journals A Review of Studies of Hormonal Adjuvant Therapy in Prostate Cancer

1999 ◽  
Vol 36 (Suppl. 2) ◽  
pp. 14-19 ◽  
Author(s):  
M. Wirth ◽  
M. Froehner
Keyword(s):  
Prostate Cancer ◽  
Adjuvant Therapy ◽  
Hormonal Adjuvant Therapy

Adjuvant Hormone Therapy after Radical Prostatectomy: Indications and Results

1997 ◽  
Vol 83 (2) ◽  
pp. 567-575 ◽  
Author(s):  
Pasquale Ditonno ◽  
Michele Battaglia ◽  
Francesco Paolo Selvaggi
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Adjuvant Therapy ◽  
Hormonal Therapy ◽  
Residual Disease ◽  
Survival Rates ◽  
Low Grade ◽  
Adjuvant Hormonal Therapy ◽  
Adjuvant Hormone Therapy ◽  
Hormonal Adjuvant Therapy

Despite recent advances in staging modalities, nearly 30–40% of patients undergoing radical prostatectomy for clinically localized prostate cancer have residual disease. In these cases, one or more of the following conditions may be present: extracapsular disease, positive margins, invasion of the seminal vesicles, lymph node metastases or the postoperative persistence of PSA values above the biological threshold. The optimal management for residual prostate cancer remains controversial and in this setting adjuvant therapy could be appropriate. In the present review we examine the conditions in which hormonal adjuvant therapy can be indicated and the results available from retrospective or non-randomized studies. From the data in the literature and in the absence of randomized prospective studies, prudent conclusions could be drawn on the efficacy of adjuvant hormonal therapy. In cases of small volume, low grade (Gleason score «7) prostate cancer in stage C or D1, radical surgery coupled with adjuvant hormonal therapy leads to survival rates in stage C similar to those in the intraprostatic stage, and in stage D1 with minimal lymph involvement, seems to delay clinical development of metastases. Finally, the quality of life associated with adjuvant therapy and the drug regimens available for this therapy are reviewed.

Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomy

2020 ◽  
pp. bmjebm-2020-111592
Author(s):  
Meera Garriga ◽  
Felix Y Feng ◽  
W Robert Lee ◽  
Julian C Hong
Keyword(s):  
Prostate Cancer ◽  
Adjuvant Therapy

UP-2.136: High Risk Localized Prostate Cancer with PSA Over 20ng/ml: What Kind of Adjuvant Therapy After Radical Prostatectomy?

Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. S274
Author(s):  
J. Djozic ◽  
J. Bogdanovic ◽  
V. Sekulic ◽  
N. Seljmesi ◽  
B. Culibrk ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Radical Prostatectomy ◽  
Adjuvant Therapy ◽  
Localized Prostate Cancer

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

2011 ◽  
Vol 22 (2) ◽  
pp. 346-351 ◽  
Author(s):  
Paweł J. Wiechno ◽  
Małgorzata Sadowska ◽  
Tomasz Kalinowski ◽  
Wojciech Michalski ◽  
Tomasz Demkow
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Adjuvant Therapy ◽  
Cognitive Functions ◽  
Anxiety And Depression
Sign in / Sign up

Export Citation Format

Share Document